Pantoprazole Triples Risk of Pneumonia in Critically Ill Patients
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Pantoprazole Triples Risk of Pneumonia in Critically Ill Patients

WINSTON-SALEM, NC -- September 14, 2009 -- Use of pantoprazole in critically ill patients needing breathing machine support triples the risk of those patients contracting pneumonia, according to a study published in a recent issue of the journal CHEST.

"As best we can tell, patients who develop hospital-acquired pneumonia or ventilator-acquired pneumonia have about a 20% to 30% chance of dying from that pneumonia," said senior author David L. Bowton, MD, Section on Critical Care, Department of Anesthesiology, Wake Forest University School of Medicine, Winston-Salem, North Carolina. "It's a significant event."

The study compared treatment with ranitidine (Zantac) and pantoprazole (Protonix, Prilosec).

In the analysis of 834 patient charts, the researchers found that hospitalised cardiothoracic surgery patients treated with pantoprazole were 3 times more likely to develop pneumonia.

Both acid-reducing drugs can make the stomach a more hospitable place for bacteria to colonize. Patients on breathing machines sometimes develop pneumonia when stomach secretions reflux into the lungs.

Current treatment guidelines to prevent pneumonia recommend raising the head of the bed for patients on breathing machines, which reduces the risk of stomach secretions getting into the lungs.

But the study's findings suggest some other steps could keep critically ill patients from developing ventilator-associated pneumonia.

Physician should consider whether an acid reducer is needed at all, said Dr. Bowton. The occurrence of stress ulcer bleeding has gone down in recent years, perhaps because patients with breathing tubes are fed earlier, and food in the stomach may neutralise or reduce the effects of stomach acid.

Bowton added that in cases where an acid reducer is needed, ranitidine is recommended, given the apparent decreased risk in developing pneumonia.

Physicians should discontinue the drug as soon as the risk of bleeding passes -- once the patient is off the breathing machine and eating, either on his/her own or through a feeding tube.

SOURCE: Wake Forest University Baptist Medical Center

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities